Gates MRI looks to Phase 3 TB vaccine trial with epidemiology study
The Bill & Melinda Gates Medical Research Institute (MRI) is conducting a TB epidemiology study: setting the stage for a Phase 3 efficacy trial for its investigational TB vaccine.
Read the full story at BioPharma-Reporter.com.